NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-070-2015-0-US-01 IL-15 and IL-15RAlpha Heterodimer Dose Escalation Regimens for Treating Conditions US 62/030,394 Abandoned
NCI E-158-2009-0-US-07 Granulysin In Immunotherapy US DIV 14/341,317 9358285 Abandoned PDF
NICHD E-057-2008-0-CA-50 Use Of Ulipristal For Treating Uterine Fibroids CA DIV 2857798 Abandoned
NCI E-291-2014-0-US-01 Method For Purifying Antibody Using PBS US 62/028,994 Abandoned
NIAID E-021-2019-0-CA-03 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN CA National Stage 2919353 Issued
NIAID E-021-2019-0-US-06 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN US ORD 14/340,519 10125172 Issued PDF
NCI E-029-2006-1-US-08 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment US National Stage 14/339,766 9217010 Issued PDF
NIAID E-021-2019-0-PCT-02 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN PCT PCT PCT/US2014/048086 Expired
NIAID E-021-2019-0-EP-09 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN EP DIV 19213895.6 Pending
NEI E-162-2016-0-US-01 GENE THERAPY FOR RETINITIS PIGMENTOSA US 62/028,638 Abandoned
NIAID E-021-2019-0-IN-08 CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN IN National Stage 201627003574 Pending
NIDDK E-102-2011-0-US-04 (N)-Methanocarba Phosphonate Analogues Of 5'-AMP As Cardioprotective Agents US DIV 14/338,987 9303053 Issued PDF
NICHD E-234-2008-2-US-03 Method for Predicting and Detecting Tumor Metastasis US DIV 14/337,408 Abandoned
NCI E-162-2009-0-US-09 Pharmaceutical Compositions Which Inhibit FKBP52-Mediated Regulation of Androgen Receptor Function and Methods of Using Same US DIV 14/336,075 9233973 Abandoned PDF
NHGRI E-055-2005-2-US-07 Farnesyl Transferase Inhibitors (FTIs) For Treatment of Laminopathies, Cellular Aging, And Artherosclerosis US CON 14/336,457 Abandoned
NIAID E-540-2013-0-CA-05 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION CA National Stage 2918264 Issued
NIAID E-540-2013-0-CH-08 Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease CH EP 14826325.4 Issued
NIAID E-540-2013-0-IT-10 Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease IT EP 14826325.4 Issued
NIAID E-540-2013-0-IE-09 Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease IE EP 14826325.4 Issued
NIAID E-540-2013-0-PL-11 Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease PL EP 14826325.4 Issued
NIAID E-540-2013-0-ES-01 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION ES EP 14826325.4 Issued
NIAID E-540-2013-0-DK-01 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION DK EP 14826325.4 Issued
NIAID E-540-2013-0-EP-06 Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease EP National Stage 14826325.4 Issued
NIAID E-540-2013-0-AU-04 Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease AU National Stage 2014290367 Issued
NIAID E-540-2013-0-PCT-02 Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease PCT PCT PCT/US2014/047324 Expired
NIAID E-540-2013-0-US-03 METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION US ORD 14/335,829 Abandoned
NIAID E-173-2014-0-US-01 REDUCING CXCR4 EXPRESSION AND/OR FUNCTION TO ENHANCE ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS US 62/026,138 Abandoned
NCI E-245-2014-0-US-01 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses US 62/026,221 Abandoned
NCATS E-074-2012-0-US-08 7-(PIPERAZIN-1-YL)-5H-[1,3,4]THIADIAZOLO[3,2-A]PYRIMIDIN-5-ONES FOR THE TREATMENT OF THROMBOTIC DISORDERS US National Stage 14/372,488 9303044 Issued PDF
NCATS E-208-2014-0-US-01 Naphthalene-containing Pyrazolo[1,5-a]pyrimidine Derivatives As Selective Inhibitors Of BMP Type 1receptors US 62/024,870 Abandoned
NCI E-159-2014-0-US-01 Polyketal Nanoparticles Including A CPG Oligodeoxynucleotide For The Treatment of Lung Cancer US 62/024,657 Abandoned
NCI E-495-2013-0-CA-04 Anti-Human Papillomavirus 16 E6 T Cell Receptors CA National Stage 2918216 Issued
NCI E-494-2013-0-ES-15 Methods of Preparing Anti-human Papillomavirus Antigen T Cells ES EP 14745056.3 Issued
NCI E-494-2013-0-NL-19 Methods of Preparing Anti-human Papillomavirus Antigen T Cells NL EP 14745056.3 Issued
NCI E-494-2013-0-DE-14 Methods of Preparing Anti-human Papillomavirus Antigen T Cells DE EP 14745056.3 Issued
NCI E-494-2013-0-FR-16 Methods of Preparing Anti-human Papillomavirus Antigen T Cells FR EP 14745056.3 Issued
NCI E-494-2013-0-EP-06 Methods of Preparing Anti-human Papillomavirus Antigen T Cells EP National Stage 14745056.3 Issued
NCI E-494-2013-0-IT-18 Methods of Preparing Anti-human Papillomavirus Antigen T Cells IT EP 14745056.3 Issued
NCI E-494-2013-0-GB-17 Methods of Preparing Anti-human Papillomavirus Antigen T Cells GB EP 14745056.3 Issued
NCI E-495-2013-0-GB-15 Anti-Human Papillomavirus 16 E6 T Cell Receptors GB EP 14748353.1 Issued
NCI E-495-2013-0-ES-13 Anti-Human Papillomavirus 16 E6 T Cell Receptors ES EP 14748353.1 Issued
NCI E-495-2013-0-IT-17 Anti-Human Papillomavirus 16 E6 T Cell Receptors IT EP 14748353.1 Issued
NCI E-495-2013-0-IE-16 Anti-Human Papillomavirus 16 E6 T Cell Receptors IE EP 14748353.1 Issued
NCI E-495-2013-0-EP-06 Anti-Human Papillomavirus 16 E6 T Cell Receptors EP National Stage 14748353.1 Issued
NCI E-495-2013-0-FR-14 Anti-Human Papillomavirus 16 E6 T Cell Receptors FR EP 14748353.1 Issued
NCI E-495-2013-0-DE-12 Anti-Human Papillomavirus 16 E6 T Cell Receptors DE EP 14748353.1 Issued
NCI E-495-2013-0-AU-03 Anti-Human Papillomavirus 16 E6 T Cell Receptors AU National Stage 2014290288 Issued
NCI E-495-2013-0-PCT-02 Anti-Human Papillomavirus 16 E6 T Cell Receptors PCT PCT PCT/US2014/046480 Expired
NCI E-494-2013-0-PCT-02 Methods of Preparing Anti-human Papillomavirus Antigen T Cells PCT PCT PCT/US2014/046478 Expired
NCI E-494-2013-0-AU-03 Methods of Preparing Anti-human Papillomavirus Antigen T Cells AU National Stage 2014290286 Abandoned